Concepedia

Zongjun Shi

ZS

Statistics

Publications

2

Citations

62

H-Index

2

Active since

2017

Affiliations

China National Pharmaceutical Group Corporation (China)(Current)

Zongjun Shi is an author at China National Pharmaceutical Group Corporation (China) specializing in diabetes, drug development, and drug discovery.

Top concepts

DiabetesMedicineBiochemistryPharmacologyDrug DiscoveryDrug DevelopmentNatural SciencesMedicinal ChemistryChronic Kidney Disease

Publications per year

2017–2020

2

Publications

2

Discovery of a Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor (HSK0935) for the Treatment of Type 2 Diabetes

Yao Li, Zongjun Shi, Lei Chen et al. · Journal of Medicinal Chemistry · 2017 · 34 citations · Full text

Selective Sglt2 Inhibitors, Pharmaceutical Chemistry, Medicinal Chemistry +17

Pharmacology and Mechanism of Action of HSK16149, a Selective Ligand of α2δ Subunit of Voltage-Gated Calcium Channel with Analgesic Activity in Animal Models of Chronic Pain

Xiaoli Gou, Xiaojuan Yu, Dongdong Bai et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 28 citations · Full text

Rows per page

1–2 of 2